Cargando…
Association of PET-based estradiol-challenge test for breast cancer progesterone receptors with response to endocrine therapy
Estrogen receptor (ER) testing of breast cancer imperfectly predicts response to endocrine therapy (ET). We hypothesize that a brief estradiol challenge will increase tumor progesterone receptor (PgR) levels only in tumors with functional ER. In this prospective, phase 2, single-center, single-arm t...
Autores principales: | Dehdashti, Farrokh, Wu, Ningying, Ma, Cynthia X., Naughton, Michael J., Katzenellenbogen, John A., Siegel, Barry A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854611/ https://www.ncbi.nlm.nih.gov/pubmed/33531464 http://dx.doi.org/10.1038/s41467-020-20814-9 |
Ejemplares similares
-
Extensive Metastatic Sarcomatoid Renal Cell Carcinoma Evaluated by (18)F-FDG PET/CT: a Case Report and Review of Literature
por: Fuser, Dominique, et al.
Publicado: (2018) -
PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging
por: Katzenellenbogen, John A.
Publicado: (2020) -
A prospective trial comparing FDG-PET/CT and CT to assess tumor response to cetuximab in patients with incurable squamous cell carcinoma of the head and neck
por: Adkins, Douglas, et al.
Publicado: (2014) -
Novel Assay for Detection of Progesterone Receptor-Interacting Endocrine Disruptors
por: Stavreva, Diana A, et al.
Publicado: (2021) -
First-in-Man Evaluation of (124)I-PGN650: A PET Tracer for Detecting Phosphatidylserine as a Biomarker of the Solid Tumor Microenvironment
por: Laforest, Richard, et al.
Publicado: (2017)